Sort
46,585 grants matching “heart failure”
'Heart Failure in the Community: Multimorbidity and Outcomes'
$794,245Veronique L Roger · Mayo Clinic Rochester · R01 · FY2016 · HL
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
$794,225Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2017 · HL
Computational Assessment of Galectin-3 Significance in Heart Failure Remodeling
$794,209Siamak Ardekani · Johns Hopkins University · R01 · FY2019 · HL
Microstructural Response of the Myocardium to Mechanical Load
$794,048David E Sosnovik · Massachusetts General Hospital · R01 · FY2021 · HL
Prevention of corneal transplant rejection using AAV-BDRK-401 therapy
$793,930Brian C Gilger · Bedrock Therapeutics, Inc. · R42 · FY2025 · EY
Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral Regurgitation
$793,920Deborah Kwon · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
Focused Imaging as a Novel Diagnostic Strategy for Aortic Stenosis
$793,868Benjamin Seth Wessler · Tufts Medical Center · R01 · FY2025 · HL
Plasma Exosomes and Vascular Dysfunction in Adults with Sleep Apnea
$793,865David Gozal · University Of Missouri-Columbia · R56 · FY2018 · HL
HDL Structure, Function and Dysfunction
$793,855Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Cardiac delivery of RNA to treat contractile disorder
$793,828Kenneth Ber Margulies · University Of Pennsylvania · R01 · FY2024 · HL
Molecular Regulation of Cardiovascular 7 TM Receptors
$793,762Robert J Lefkowitz · Duke University · R01 · FY2020 · HL
Molecular understanding of membrane sensors
$793,611Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2022 · HL
'Heart Failure in the Community: Multimorbidity and Outcomes'
$793,509Veronique L Roger · Mayo Clinic Rochester · R01 · FY2017 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device
$793,479O. H. Frazier · Texas Heart Institute · R01 · FY2015 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE
$793,340Johns Hopkins University · U01 · FY2002 · HL
The Impact of Diabetes on Revascularization in BEST-CLI
$793,319Joshua A Beckman · Vanderbilt University Medical Center · R01 · FY2017 · HL
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy
$793,250Deok-Ho Kim · Johns Hopkins University · UG3 · FY2020 · TR
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories and prognostic significance
$793,239Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2020 · HL
Effects of Manually Recorded or Automatically Transmitted Home Blood Pressures with or without Automated Patient Feedback on Hypertension Care
$793,184Stephen Persell · Northwestern University At Chicago · R01 · FY2025 · HL
Tissue Sodium, Inflammation, and Blood Pressure in MESA
$793,066Thomas J Wang · Vanderbilt University Medical Center · R01 · FY2016 · HL
Image Guided Delivery of Bioresponsive Hydrogels
$793,000Albert J Sinusas · Yale University · R01 · FY2020 · HL
Microstructural Response of the Myocardium to Mechanical Load
$792,961David E Sosnovik · Massachusetts General Hospital · R01 · FY2024 · HL
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
$792,922Gary K Owens · University Of Virginia · R01 · FY2023 · HL
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
$792,922Gary K Owens · University Of Virginia · R01 · FY2022 · HL
Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap
$792,922Gary K Owens · University Of Virginia · R01 · FY2025 · HL